share_log

多瑞医药(301075.SZ):拟将2630万元超募资金用于永久补流

Tori Pharmaceutical (301075.SZ): plans to use 26.3 million yuan of super-raised funds for permanent replenishment

格隆滙 ·  Dec 26, 2021 23:22

301075.SZ announced that the company held the ninth meeting of the first session of the Board of Directors and the eighth meeting of the first session of the Supervisory Committee on December 24, 2021, and examined and passed the "motion on the use of part of the over-raised funds to permanently replenish current funds", agreeing that the company should use 26.3 million yuan of over-raised funds for permanent replenishment of liquidity. The bill still needs to be submitted to the company's first interim general meeting of shareholders in 2022 for consideration and approval.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment